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Abstract
Increasing cure rates for childhood cancers have resulted in a population of adult childhood cancer 
survivors (CCS) that are at risk for late effects of cancer-directed therapy. Our objective was to 
identify facilitators and barriers to primary care physicians (PCPs) providing late effects screening 
and evaluate information tools PCPs perceive as useful. We analyzed surveys from 351 practicing 
internal medicine and family practice physicians nationwide.
A minority of PCPs perceived that their medical training was adequate to recognize late effects of 
chemotherapy (27.6%), cancer surgery (36.6%), and radiation therapy (38.1%). Most PCPs (93%) 
had never used Children’s Oncology Group guidelines, but 86% would follow their 
recommendations. Most (84–86%) PCPs stated that they had never received a cancer treatment 
summary or survivorship care plan but (>90%) thought these documents would be useful. PCPs 
have a low level of awareness and receive inadequate training to recognize late effects.
Overall, PCPs infrequently utilize guidelines, cancer treatment summaries, and survivorship care 
plans, although they perceive such tools as useful. We have identified gaps to address when 
providing care for CCS in routine general medical practice.
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Introduction
Dramatic increases in cure rates for childhood cancer patients over the past 30 years have 
resulted in a growing population of adults who are childhood cancer survivors (CCS)[1]. 
These adults bear the unintended burden of successful cancer therapy, that is, morbidity and 
mortality that may not arise until years after the initial cancer treatment is complete. 
Approximately 250,000 adult CCS in the United States are at risk for late effects of their 
cancer therapy [2]. Chronic medical conditions are reported by 62.3% of the adult CCS 
population [2]. General medical care for this population must address the late effects of 
childhood cancer.
To guide health care delivery for adult CCS, the Children’s Oncology Group (COG) created 
the Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young 
Adult Cancers [3]. Little is known about awareness and implementation of these guidelines. 
In a 2007 study of adult CCS, 41% of female patients that guidelines identified as high risk 
for breast cancer reported having a recommended mammogram in the past two years [4]. 
This same study found that only 28% of patients at high risk for cardiac dysfunction 
reported receiving a recommended echocardiogram. These proportions fall to 33% reporting 
a mammogram, and 21% reporting an echocardiogram, if the CCS were followed solely in a 
primary care setting [4]. Taken together, these findings suggest low guideline adherence 
among those adult CCS at high risk for late effects.
Opportunities exist for improved guideline adherence. Eighty-seven percent of a cohort of 
14,370 CCS reported general contact with the health care system over a two-year period [5]. 
Of all cancer-related visits made to physicians’ offices in 2001–2, about one-third were 
made to primary care physicians (PCPs) [6]. Clearly, PCPs will play an important role in 
promoting evidence-based follow-up care for adult CCS.
The practice patterns of PCPs providing care for CCS is largely unknown. The Institute of 
Medicine [6] and Livestrong Foundation [7] have suggested that cancer survivors be 
provided documents with recommendations for follow-up care and health promotion. The 
treating oncology team is encouraged to summarize the cancer therapy a patient has received 
(cancer treatment summary) and outline plans for late effect surveillance (cancer 
survivorship care plan) so that this information can be shared with both the patient and other 
physicians.
The aim of our study was to identify facilitators and barriers to PCPs providing optimal care 
for CCS. Through a PCP survey, we set out to examine what information tools PCP’s 
perceive as useful, including practice guidelines, cancer treatment summaries, and 
survivorship care plans, as well as what physician characteristics are associated with the 
perceptions and use of these information tools.
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Materials and Methods
Sample
We surveyed 1,500 individuals randomly sampled from a nationwide pool of general 
internal medicine and family practice physicians in the American Medical Association 
(AMA) Physician Masterfile. The AMA Masterfile includes physicians regardless of AMA 
membership and is considered representative of the U.S. physician population. Stratified 
sampling based upon four regions (as defined by the U.S. Census Bureau) was conducted to 
ensure equal representation in case of regional variation.
Survey Development
Survey items were based upon a model for implementing change in the health care setting 
[8]. This model utilizes behavioral theories on implementing change to assess stages-of-
change in clinical practice [9]. The survey items addressed stages of change in practice 
under the categories of orientation, insight, and acceptance. Orientation addresses physician 
awareness and interest in the medical problems of adult CCS. Insight focuses upon 
physician understanding of current medical knowledge, practice routines, and barriers to 
care. Acceptance comprises physician acceptance and attitude towards practice change.
To develop the survey, we engaged experts from multiple clinical disciplines (PCPs, 
pediatric hematology/oncology physicians, nurse practitioners, registered nurses), as well as 
behavioral scientists. The survey was refined using the Tailored Design Method [10] and 
item-by-item review to gain feedback on item content, readability, ordering, and general 
understandability.
Survey Administration
The survey was mailed to participants with a cover letter, prepaid return envelope, and $1 
incentive. Subjects that refused to participate were instructed to return blank surveys. Non-
responders were sent two additional mailings, one month apart, from February 1 to April 5, 
2008. Surveys were received for 4 months following the initial mailing. Human subjects 
approval was provided by the Indiana University-Purdue University IRB.
Measures
Practice and physician characteristics: From the AMA Masterfile, physician characteristics 
included gender, specialty (family practice or internal medicine), training status (in-training 
or complete), and date of medical school completion; practice characteristics included 
census region. From the survey, practice characteristics included practice type and number 
of outpatient visits per week. Stage of change: physicians completed Likert scale survey 
items addressing the three stages of change: orientation, insight, and acceptance. Useful 
information sources and formats were also ranked by physicians. The survey is available as 
supplemental digital content.
Data Analysis
Responders were defined as primary care physicians who completed at least one of the items 
analyzed in the survey. Responders were compared to non-responders on sociodemographic 
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and practice characteristics using chi-squared tests or t-tests. The distribution of responses 
by stage of change was assessed. Useful information sources and formats were summarized 
according to what percentage of physicians ranked each item as the most useful.
Frequencies were generated for physician demographics and other survey measures. In order 
to compare training adequacy across different knowledge domains (chemotherapy, radiation 
therapy, and surgery), paired t-tests compared scales representing the sum of the Likert 
scores (1–5) for the questions of interest (Insight section). For the purpose of multivariable 
models, binary variables were created for (1) the availability of treatment summaries and 
survivorship care plans (occasionally or more often vs. never), and (2) the usefulness of 
treatment summaries and survivorship care plans (not strongly agree vs. strongly agree). The 
following explanatory physician characteristics were considered in regression models: 
gender, specialty, years since medical school graduation, number of outpatients seen in a 
typical week, and census region. Previous literature has shown these explanatory 
characteristics to be associated with physician behavior. Specifically, cancer screening has 
been associated with outpatient volume [11], physician age [12], gender [13], specialty [14], 
and local practice norms [15]. The behavioral model of access to medical care [16] also 
suggests that health care delivery is influenced by provider-related characteristics. Post-hoc 
analyses restricted the models to those PCPs who indicated that they had participated in the 
care of a cancer survivor; however, the results were not substantively different.
All analyses accounted for the stratified sampling design to allow for correct point estimates 
and standard errors. For the comparison of responders to non-responders, the weights were 
the inverse of the probability of being selected for survey mailing within each region. For 
the analyses of responders, these weights were adjusted to reflect the probabilities of 
responding within each region. All analyses were performed using SAS version 9.1.3 (SAS 
Institute, Inc., Cary, NC, USA).
Results
Response Characteristics
Surveys were returned by 351 U.S. physicians with complete or partial data for analysis 
(Figure 1). The overall physician response rate was 23%. Response rates were higher for 
physicians in family practice than general internal medicine (30.2% vs. 16.5%, p<.0001). 
There were no other significant differences in physician and practice characteristics between 
responders and non-responders. Sample characteristics for respondents are shown in Table I.
Survey responses by Stage of Change
Responses were grouped according to the stages of change model (Table II).
A. Orientation: Awareness and interest in the medical problems of adult CCS
—About 40% of PCPs stated that they had never participated in the medical care of a CCS, 
and about 37% were neutral or disagreed with the statement that the problems of CCS were 
important to their practice.
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B. Insight: Understanding current medical knowledge—About 40% of PCPs were 
aware of practice guidelines for CCS. A minority of PCPs perceived that their medical 
training was adequate to recognize late effects of chemotherapy (27.5%), cancer surgery 
(36.5%), and radiation therapy (38.1%). PCPs rated their training adequacy approximately 
the same for surgery and radiation (mean = 2.82 and 2.84, respectively, p=.6210), and they 
rated their training adequacy for both surgery and radiation higher than chemotherapy (mean 
2.55, p <.0001 for both).
C. Insight: Understanding barriers and current practice routines—Having 
adequate time in the patient visit to discuss late effects was a barrier for 42% of PCPs. 
Almost 33% of PCPs agreed that cancer survivors did not perceive late effects as a risk to 
their health and 39% agreed that adult CCS had problems with insurance coverage of the 
recommended screening for late effects.
Majorities of PCPs agreed that it was difficult to get a cancer history from a patient (65.0%) 
and from the treating oncologist (51.4%). Most PCPs stated that they had never received a 
cancer treatment summary or survivorship care plan (84% and 86%, respectively), and 93% 
of PCPs had never used the COG late effects guidelines. Only years since graduated from 
medical school was significantly associated with the availability of a care plan (Table III, 
OR = 1.04, p = 0.03)
D. Acceptance: Acceptance and attitude towards change—Although the reported 
receipt of cancer treatment summaries or survivorship care plans were low, greater than 90% 
of PCPs thought it would be useful to receive these continuity of care documents. Similarly, 
86% of PCPs agreed that they would follow the COG late effects guidelines.
In multivariable models (Table III), females were more likely to strongly agree that a 
treatment summary was useful (OR=0.53). In the U.S., PCPs practicing in the Midwest were 
more likely than PCPs in the South to agree that a treatment summary was useful 
(OR=3.59). None of the provider variables were associated with report of a treatment 
summary being available. PCPs with more years post-graduation since medical school were 
less likely to agree that a care plan was useful (OR=1.04). Females were more likely to 
agree that a care plan was useful (OR=0.43). There was also regional variation in the 
perceived usefulness of care plans. Those with more years post-graduation since medical 
school were more likely to report that a care plan was available (OR = 1.04).
Information sources or format
Sources of information on adult CCS were ranked by PCPs. The oncologist was reported as 
most important, with 44.6% of number one rankings, followed by the Internet (33.2%), 
textbooks (9.7%), journal articles (7.1%), primary care colleagues (3%), and other specialty 
physicians (2.5%). When asked to identify the most useful format for a medical screening 
prompt, PCPs most often ranked a letter in the mail (41.2%) as the most useful prompt, 
followed by a computer prompt or flow sheet in the chart (35.1%), a telephone call to the 
office (10.6%), email reminder (6.7%), website with patient information (5.7%), and 
telephone hotline (0.7%).
Sima et al. Page 5
J Pediatr Hematol Oncol. Author manuscript; available in PMC 2015 August 13.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Discussion
Recent estimates show that 1/640 people between the ages of 20–39 years in the U.S. have a 
history of cancer [6]. Given the increasing number of adult CCS, and the fact that about 50% 
of our sample reported seeing between 76–125 patients per week, it is unlikely that 40% of 
PCPs “never” participate in the medical care adult CCS as was self-reported. These findings 
may be better explained by a lack of PCP awareness about the presence of CCS in their 
practice. This lack of awareness may represent a communication problem among physicians 
and patients, and thus, may potentially be reduced with cancer treatment summaries and 
survivorship care plans. Provider education regarding the issues of adult CCS is a goal of 
several national organizations [6,7,17], and future interventions should take into account the 
broad lack of awareness about the high prevalence of adult CCS in the general population. 
PCPs by no means discounted the needs of CCS, as the majority agreed that the problems of 
childhood cancer survivors were important to their medical practice.
An alternative explanation for the finding that few PCPs reporting being exposed to a 
survivor of childhood cancer is that such patients may have limited access to health care. 
Adult CCS are less likely to have health insurance coverage [18] and uninsured survivors 
utilize health care (both cancer-specific and general health care resources) less than those 
with insurance [19]. Survivors of adolescent and young adult cancer report more cost 
barriers to health care access and less utilization than the general population, regardless of 
whether they had insurance or not [20]. Therefore, CCS may simply be in the primary care 
office less often.
Medical training
A previous review of residency training curriculums for both internal medicine and family 
practice revealed a lack of information about cancer survivorship [21]. The majority of 
PCP’s in our sample perceived the adequacy of their training to recognize late effects of 
cancer therapy to be poor. Our findings suggest PCPs are more comfortable recognizing late 
effects from surgery and radiation than chemotherapy, perhaps because the risks of surgical 
procedures are similar when performed for cancer and non-cancer purposes. For the purpose 
of clinical follow-up, the risk stratification of CCS has been proposed, including the 
classification of patients who receive only surgical therapy into a low-risk group of CCS 
[22]. Nonetheless, our data suggest that PCPs will need further training to effectively 
participate in the follow-up care of all risk groups.
Practice guidelines, cancer treatment summaries and survivorship care plans
The COG guidelines are the most complete source of information about the late effects of 
childhood cancer available. However, the majority (60.4%) of PCPs did not know that COG 
guidelines existed, and only 7.4% of PCPs reported using COG guidelines frequently or very 
frequently. To increase availability, the COG guidelines were posted on the National 
Guideline Clearinghouse (Agency for Healthcare Research and Quality). Multiple, 
additional channels of dissemination will clearly be necessary to promote broader 
knowledge and use of COG guidelines among PCPs..
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There is strong support from national organizations and policymakers for the use of cancer 
treatment summaries and survivorship care plans [6,7]. However, little is known about how 
these tools have been implemented among PCPs caring for childhood cancer survivors, their 
level of acceptance among PCPs, and what physician factors may be associated with their 
implementation. Canadian PCPs reported that a survivorship care plan would be the most 
useful tool to help them provide follow-up medical care for adult-onset cancer survivors 
[23]. Among U.S. PCPs seeing adult CCS, we found the use of cancer treatment summaries 
and survivorship care plans was low (<20%), yet the perceived usefulness was very high 
(>90%). While low levels of implementation were present in 2008, use of these tools may be 
somewhat higher now due to the significant amount of attention they have received. When 
implemented, it appears that PCPs naïve to these tools will be receptive to their use at the 
outset. Future interventions should explore tailoring messages about cancer treatment 
summaries and survivorship care plans to male and older physicians who are less likely to 
perceive them as useful.
Information sources
The oncologist was identified as the PCPs’ most important source of information about late 
effects of childhood cancer, although about half of PCPs agreed that it was difficult to get 
the cancer history from the treating oncologist. The second most important source of 
information was the Internet. Our results complement previous findings that patients first 
obtain information from the Internet but prefer information from their physicians[24]. The 
Passport for Care is an internet based resource that is beginning to be used by oncologists 
and patients and may be a resource of growing importance. The sources and accessibility of 
information by PCPs and patients need further attention to ensure optimal delivery of 
accurate, timely information about adult CCS.
Given that 42% of PCPs agreed that adequate time was a barrier to discussing late effects, 
efficient methods of communication will continue to need to be development among PCPs, 
oncologists and cancer survivors. Health care information systems, such as patient and 
physician reminders or Web-based patient portals, may help to coordinate the efforts of 
physicians caring for adult CCS.
The results of this study should be interpreted in the context of its limitations, including the 
low response rate. Of note, physician mail surveys typically have low response rates (29–
43%), with a trend towards decreasing responsiveness [25]; thus, our response rate (24%) is 
consistent within these patterns. Furthermore, there is no single acceptable survey response 
rate [26], and a low response rate does not alone affect the validity of the data collected [27] 
“as long as the nonresponse effects are documented, tested, and understood.” [28]
We found that our responders and non-responders were similar with the exception of 
specialty type. It is possible that the language used in the survey influenced the response rate 
and introduced the response bias seen between specialty types. A number of surveys were 
returned unanswered from PCPs with comments to the effect that they do not see children in 
their practice. The focus of the survey on “an adult survivor of childhood cancer” was 
described in the cover letter; however, use of the phrase “childhood” cancer survivor may 
have influenced the differential response rate by suggesting a pediatric population. The 
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increased proportion of respondents who were family practice physicians, compared to 
general internists, lends support to this supposition given that family practice physicians are 
more likely to include pediatrics within their scope of practice. Future research and 
educational materials targeting the needs of CCS will need to consider how best to describe 
this population so as to be easily recognizable by PCPs as applying to their practice.
The strengths of our study include the large national sample of physicians. Few studies to 
our knowledge have evaluated the needs, perceptions or attitudes of adult primary care 
providers caring for adult survivors of childhood cancer. Prior studies have discussed 
models of care for cancer survivors and the role of the primary care physician [29]. PCPs 
caring for adult colorectal cancer survivors report that the topic of survivor care is important, 
but they need more information about long term complications from cancer therapy [30]. 
Primary care physician perspectives on the care for breast and colorectal cancer survivors 
has also been reported [31, 31, 21]. But again, the current study occupies a unique niche in 
evaluating the adult PCP perspective on caring for adult CCS.
Furthermore, we collected data so as to inform future interventions to change medical 
practice and improve the care of adult CCS. We found that PCPs have a low level of 
awareness about the medical issues of adult CCS; receive inadequate medical training to 
recognize late effects of treatment; and infrequently use cancer treatment summaries, 
survivorship care plans, and COG guidelines. Future research should study the impact of 
cancer treatment summaries and survivorship care plans upon the quality of care and clinical 
outcomes of CCS. By understanding the perceptions of PCPs, we can better understand how 
to incorporate recommended follow-up care for CCS into routine general medical practice.
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Figure 1. 
Account of Survey Responses
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Table I
Characteristics of Physician Survey Respondents (n=351)
Characteristic Primary Care Physician Respondents
(standard error)
Gender
  Male 60.1 % (2.7%)
  Female 39.9% (2.7%)
Training status
  In-training 6.0% (1.3%)
  Complete 94.0% (1.3%)
Specialty
  Family Practice 64.2% (2.6%)
  Internal Medicine 35.8% (2.6%)
Medical school graduation date
  Prior to 1970 5.3% (1.3%)
  1970–1980 14.0% (1.9%)
  1980–1990 24.1% (2.3%)
  1990–2000 38.7% (2.7%)
  2000–2007 17.8% (2.1%)
Main practice Setting*
  Office-Based 76.7% (2.3%)
  Hospital 5.3% (1.2%)
  Multispecialty Practice 3.8% (1.0%)
  Managed Care 2.5% (0.9%)
  Academic 7.8% (1.4%)
  Government 3.9% (1.1%)
Weekly outpatient visits†
  25 or fewer 8.7% (1.5%)
  26–50 11.3% (1.7%)
  51–75 18.6% (2.2%)
  76–100 30.6% (2.6%)
  101–125 20.3% (2.3%)
  126 or more 10.6% (1.7%)
*
n=336
†
n=337
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Table III
Multiple logistic regression models for binary outcomes
Treatment
Summary
Useful to
Manage
Patient*
Treatment
Summary is
Available**
Care Plan
Useful to
Manage
Patient*
Care Plan is
Available**
Effect
OR
Estimate
95% CI
OR
Estimate
95% CI
OR
Estimate
95% CI
OR
Estimate
(95% CI)
Years since graduated Medical School 1.02 (0.997, 1.05) 1.02 (0.99, 1.05) 1.04 (1.01, 1.06)†† 1.04 (1.003, 1.07)†
Number of Outpatients (ref. ≥ 126)
≥ 25 0.56 (0.15, 2.12) 0.63 (0.15, 2.64) 0.60 (0.16, 2.17) 0.19 (0.03, 1.11)
26–50 0.86 (0.28, 2.70) 0.48 (0.13, 1.84 0.37 (0.10, 1.37 0.63 (0.17, 2.40)
51–75 0.94 (0.34, 2.62) 0.42 (0.13, 1.35 0.70 (0.23, 2.13 0.27 (0.08, 0.96)
76–100 1.02 (0.41, 2.52) 0.47 (0.17, 1.27) 0.82 (0.31, 2.15) 0.42 (0.15, 1.18)
101–125 1.13 (0.44, 2.92) 0.52 (0.18, 1.50) 1.03 (0.38, 2.75 0.38 (0.12, 1.16)
Female (ref. Male) 0.53 (0.30, 0.95)† 0.91 (0.44, 1.88) 0.43 (0.23, 0.81)†† 0.69 (0.29, 1.61)
Family Practice (ref. Internal Medicine) 1.13 (0.65, 1.99) 2.08(0.95, 4.54) 1.02 (0.56, 1.86) 1.23 (0.55, 2.78)
Census Region (ref. Midwest)
West 1.86 (0.85, 4.10) 0.47(0.18, 1.21) 2.42 (1.05, 5.61)† 0.67 (0.25, 1.84)
Northeast 1.92 (0.89, 4.19) 1.00 (0.45, 2.21) 1.96 (0.83, 4.66)‡ 0.98 (0.40, 2.37)
South 3.59 (1.74, 7.44)†† 0.70 (0.30, 1.62) 4.48 (2.02, 9.91) †† 0.83 (0.34, 2.07)
*Not Strongly Agree vs Strongly Agree
**Occasionally or More Often vs Never
†0.01 < p < 0.05
††p < 0.01
‡Northeast different from South: OR=0.44 (95% CI: 0.21, 0.94), 0.01 < p < .05
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